Comments
Loading...
Stime degli utili, EPS e fatturato
Amneal Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
ott 30
Stima EPS
$0.150
Stima dei ricavi trimestrali
$769.66M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$2.85B
Analizza lo storico degli utili di Amneal Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
AMRX | Amneal Pharmaceuticals | $0.16 | $0.15 | — | — | $702.47M | $769.66M | — | — | 10/30/2025 | |
AMRX | Amneal Pharmaceuticals | $0.16 | $0.17 | $0.25 | 47.06% | $701.78M | $736.98M | $725.00M | -1.63% | 08/05/2025 | |
AMRX | Amneal Pharmaceuticals | $0.14 | $0.15 | $0.21 | 40.00% | $659.19M | $715.49M | $695.42M | -2.81% | 05/02/2025 | |
AMRX | Amneal Pharmaceuticals | $0.14 | $0.15 | $0.12 | -20.00% | $616.98M | $708.07M | $730.52M | 3.17% | 02/28/2025 | |
AMRX | Amneal Pharmaceuticals | $0.19 | $0.13 | $0.16 | 23.08% | $620.04M | $696.80M | $702.47M | 0.81% | 11/08/2024 | |
AMRX | Amneal Pharmaceuticals | $0.19 | $0.14 | $0.16 | 14.29% | $599.05M | $658.14M | $701.78M | 6.63% | 08/09/2024 | |
AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.14 | 55.56% | — | $619.03M | $659.19M | 6.49% | 05/03/2024 | |
AMRX | Amneal Pharmaceuticals | — | $0.09 | $0.14 | 55.56% | — | $634.23M | $616.98M | -2.72% | 03/01/2024 | |
AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.19 | 46.15% | — | $595.27M | $620.04M | 4.16% | 11/07/2023 | |
AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.19 | 90.00% | — | $562.49M | $599.05M | 6.50% | 08/04/2023 | |
AMRX | Amneal Pharmaceuticals | — | $0.10 | $0.12 | 20.00% | — | $537.31M | $557.54M | 3.77% | 05/05/2023 | |
AMRX | Amneal Pharmaceuticals | — | $0.21 | $0.23 | 9.52% | — | $579.91M | $609.76M | 5.15% | 03/02/2023 | |
AMRX | Amneal Pharmaceuticals | — | $0.18 | $0.14 | -22.22% | — | $564.15M | $545.56M | -3.30% | 11/04/2022 | |
AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.19 | -5.00% | — | $536.34M | $559.36M | 4.29% | 08/05/2022 | |
AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.12 | -7.69% | — | $503.97M | $497.63M | -1.26% | 05/04/2022 | |
AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.18 | -10.00% | — | $537.35M | $536.90M | -0.08% | 03/02/2022 | |
AMRX | Amneal Pharmaceuticals | — | $0.20 | $0.21 | 5.00% | — | $545.06M | $528.59M | -3.02% | 11/03/2021 | |
AMRX | Amneal Pharmaceuticals | — | $0.19 | $0.25 | 31.58% | — | $523.25M | $535.08M | 2.26% | 08/09/2021 | |
AMRX | Amneal Pharmaceuticals | — | $0.18 | $0.20 | 11.11% | — | $515.34M | $493.11M | -4.31% | 05/07/2021 | |
AMRX | Amneal Pharmaceuticals | — | $0.13 | $0.14 | 7.69% | — | $507.02M | $510.03M | 0.59% | 02/26/2021 | |
AMRX | Amneal Pharmaceuticals | — | $0.12 | $0.16 | 33.33% | — | $482.11M | $519.29M | 7.71% | 11/06/2020 |
Amneal Pharmaceuticals (AMRX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $0.25 | $0.17 | 47.1 % |
| Q1 | 2025-05-02 | $0.21 | $0.15 | 40.0 % |
| Q4 | 2025-02-28 | $0.12 | $0.15 | -20.0 % |
| Q3 | 2024-11-08 | $0.16 | $0.13 | 23.1 % |
Amneal Pharmaceuticals (AMRX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $725.00M | $736.98M | -1.63 % |
| Q1 | 2025-05-02 | $695.42M | $715.49M | -2.81 % |
| Q4 | 2025-02-28 | $730.52M | $708.07M | 3.17 % |
| Q3 | 2024-11-08 | $702.47M | $696.80M | 0.81 % |
FAQ
Quando Amneal Pharmaceuticals (NASDAQ:AMRX) riporterà gli utili?
Si prevede che Amneal Pharmaceuticals (AMRX) fornisca risultati il ottobre 30, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Amneal Pharmaceuticals (NASDAQ:AMRX)?
L'EPS effettivo era $0.25, che superato la stima di $0.17.
Quali sono state le entrate di Amneal Pharmaceuticals (NASDAQ:AMRX)?
Le entrate effettive sono state $725M, che mancato la stima di $737M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.